Lessee, Operating Lease, Liability, Undiscounted Excess Amount of Y-mAbs Therapeutics, Inc. from 31 Mar 2019 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Y-mAbs Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD history and change rate from 31 Mar 2019 to 30 Jun 2025.
  • Y-mAbs Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 30 Jun 2025 was $1,322,000, a 1209% increase year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Change (%)

Y-mAbs Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $1,322,000 +$1,221,000 +1209% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $38,000 -$36,000 -49% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $53,000 -$50,000 -49% 31 Dec 2024 10-Q 08 Aug 2025 2025 Q2
Q3 2024 $76,000 -$53,000 -41% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $101,000 -$31,000 -23% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $74,000 -$86,000 -54% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $103,000 -$36,000 -26% 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 $129,000 -$29,000 -18% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $132,000 -$100,000 -43% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $160,000 -$124,000 -44% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $139,000 -$200,000 -59% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $158,000 -$70,000 -31% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $232,000 -$44,000 -16% 30 Jun 2022 10-Q 08 Aug 2022 2021 Q3
Q1 2022 $284,000 -$47,000 -14% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $339,000 -$59,000 -15% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $228,000 -$268,000 -54% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $276,000 -$147,000 -35% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $331,000 -$146,000 -31% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $398,000 -$136,000 -25% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $496,000 -$117,000 -19% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $423,000 -$254,000 -38% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $477,000 -$219,000 -31% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $534,000 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $613,000 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 $677,000 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $696,000 31 Mar 2019 10-Q 10 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.